-
Something wrong with this record ?
Venetoclax-failed monotherapy in B-lymphoproliferative neoplasms responded to combination of venetoclax with immunochemotherapy: A report of two cases
P. Turcsányi, E. Kriegova, L. Henzlova, L. Raida, R. Urbanova, T. Papajik,
Language English Country Great Britain
Document type Case Reports, Editorial, Research Support, Non-U.S. Gov't
Persistent link
https://www.medvik.cz/link/bmc20028062
Grant support
NV16-32339A
MZ0
CEP Register
- MeSH
- Bridged Bicyclo Compounds, Heterocyclic administration & dosage MeSH
- Hematologic Neoplasms pathology therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Lymphoproliferative Disorders pathology therapy MeSH
- Adoptive Transfer * MeSH
- Sulfonamides administration & dosage MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Editorial MeSH
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028062
- 003
- CZ-PrNML
- 005
- 20210114152910.0
- 007
- ta
- 008
- 210105s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.leukres.2020.106373 $2 doi
- 035 __
- $a (PubMed)32466828
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Turcsányi, P $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic. Electronic address: Peter.Turcsanyi@fnol.cz.
- 245 10
- $a Venetoclax-failed monotherapy in B-lymphoproliferative neoplasms responded to combination of venetoclax with immunochemotherapy: A report of two cases / $c P. Turcsányi, E. Kriegova, L. Henzlova, L. Raida, R. Urbanova, T. Papajik,
- 650 12
- $a převzatá imunita $7 D019264
- 650 _2
- $a bicyklické sloučeniny heterocyklické $x aplikace a dávkování $7 D019086
- 650 _2
- $a hematologické nádory $x patologie $x terapie $7 D019337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lymfoproliferativní nemoci $x patologie $x terapie $7 D008232
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a sulfonamidy $x aplikace a dávkování $7 D013449
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a úvodníky $7 D016421
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kriegova, E $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Henzlova, L $u Department of Nuclear Medicine, University Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Raida, L $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Urbanova, R $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Papajik, T $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic.
- 773 0_
- $w MED00003141 $t Leukemia research $x 1873-5835 $g Roč. 94, č. - (2020), s. 106373
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32466828 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114152908 $b ABA008
- 999 __
- $a ok $b bmc $g 1608397 $s 1119242
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 94 $c - $d 106373 $e 20200519 $i 1873-5835 $m Leukemia research $n Leuk Res $x MED00003141
- GRA __
- $a NV16-32339A $p MZ0
- LZP __
- $a Pubmed-20210105
